Janssen Sues Sandoz Over Alzheimer's Drug Patent
Two Johnson & Johnson subsidiaries and their licensing partner have launched a patent infringement suit against Novartis AG's generics arm, Sandoz Inc., after the generics maker filed an abbreviated new drug...To view the full article, register now.
Already a subscriber? Click here to view full article